Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / IMAB - Week In Review: Wuhan Binhui Raises $47 Million For Oncolytic Virus Products

IMAB - Week In Review: Wuhan Binhui Raises $47 Million For Oncolytic Virus Products

I-MAB
  • Wuhan Binhui Biopharm closed a $47 million Series B financing to support its R&D of oncolytic virus products.
  • Amoy Diagnostics, a Shanghai novel molecular diagnostics company, signed a collaboration agreement to develop companion diagnostics for AstraZeneca drugs.
  • Hangzhou Ascletis Pharma reported that its oral small molecule 3CLpro inhibitor was a more effective treatment for COVID-19 in preclinical tests than rival candidates.

For further details see:

Week In Review: Wuhan Binhui Raises $47 Million For Oncolytic Virus Products
Stock Information
Company Name: I-MAB
Stock Symbol: IMAB
Market: NASDAQ
Website: i-mabbiopharma.com
Menu
IMAB IMAB Quote IMAB Short IMAB News IMAB Articles IMAB Message Board
Get IMAB Alerts

News, Short Squeeze, Breakout and More Instantly...